Human circulating antibody-producing B cell as a predictive measure of mucosal immunity to poliovirus

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Dey, Ayan ^a   Molodecky, Natalie A ^b   Verma, Harish ^b   Sharma, Prashant ^a,c   Yang, Jae Seung ^a   Saletti, Giulietta ^a   Ahmad, Mohammad ^b   Bahl, Sunil K ^b   Wierzba, Thomas F ^a,d   Nandy, Ranjan K ^e   Deshpande, Jagadish M ^f   Sutter, Roland W ^b   Czerkinsky, Cecil ^a,g  

^a International Vaccine Institute   (South Korea)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Seoul National University College of Medicine   (South Korea)

^d PATH   (United States)

^e NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^f Enterovirus Research Centre   (India)

^g INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; POLIOMYELITIS VACCINE; ORAL POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL HOMING; CHILD; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FECES ANALYSIS; HUMAN; HUMAN CELL; MUCOSAL IMMUNITY; POLIOMYELITIS; VIRUS EXCRETION; VIRUS NEUTRALIZATION; BLOOD; CLASSIFICATION; CLINICAL TRIAL; FECES; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOLOGY; INFANT; METABOLISM; OUTCOME ASSESSMENT; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SECONDARY IMMUNIZATION; VACCINATION; VIROLOGY;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FECES; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; OUTCOME ASSESSMENT (HEALTH CARE); POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; VACCINATION;

EID: 84953807416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146010     Document Type: Article

References (30)

1. Progress towards polio eradication worldwide. Wkly Epidemiol Rec 2014-2015. 2015;; 90.
2. Hammon WM, Coriell LL, Ludwig EH, Mc AR, Greene AE, Sather GE, et al. Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratoryconfirmed cases. Journal of the American Medical Association. 1954; 156:21-7. PMID: 13183798
3. Immunization, Vaccines and Biologicals. (WHO/IVB/04.10) Geneva, World Health Organization; 2004.
4. Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. The Journal of infectious diseases. 1991; 163:1-6. PMID: 1845806
5. Herremans TM, Reimerink JH, Buisman AM, Kimman TG, Koopmans MP. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. Journal of immunology (Baltimore, Md: 1950). 1999; 162:5011-8.
6. Svennerholm AM, Hanson LA, Holmgren J, Jalil F, Lindblad BS, Khan SR, et al. Antibody responses to live and killed poliovirus vaccines in the milk of Pakistani and Swedish women. J Infect Dis. 1981; 143:707-11. PMID: 6894606
7. Mestecky J, Czerkinsky C, Russell MW, Brown TA, Prince SJ, Moldoveanu Z, et al. Induction and molecular properties of secretory and serum IgA antibodies specific for environmental antigens. Ann Allergy. 1987; 59:54-9. PMID: 3318587
8. Wright PF, Wieland-Alter W, Ilyushina NA, Hoen AG, Arita M, Boesch AW, et al. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. The Journal of infectious diseases. 2014; 209:1628-34. doi: 10.1093/infdis/jit671 PMID: 24459191
9. Saletti G, Cuburu N, Yang JS, Dey A, Czerkinsky C. Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood. Nature protocols. 2013; 8:1073-87. doi: 10.1038/nprot.2013.058 PMID: 23660756
10. Deenen GJ, Kroese FG. Kinetics of B cell subpopulations in peripheral lymphoid tissues: evidence for the presence of phenotypically distinct short-lived and long-lived B cell subsets. International immunology. 1993; 5:735-41. PMID: 8103670
11. Huang KY, Li CK, Clutterbuck E, Chui C, Wilkinson T, Gilbert A, et al. Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model. The Journal of infectious diseases. 2014; 209:1354-61. doi: 10.1093/infdis/jit650 PMID: 24415790
12. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annual review of immunology. 2005; 23:487-513. PMID: 15771579
13. Stevens RH, Saxon A. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization. J Clin Invest. 1978; 62:1154-60. PMID: 311781
14. Czerkinsky C, Prince SJ, Michalek SM, Jackson S, Russell MW, Moldoveanu Z, et al. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A. 1987; 84:2449-53. PMID: 3470804
15. Quiding-Jarbrink M, Nordstrom I, Granstrom G, Kilander A, Jertborn M, Butcher EC, et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest. 1997; 99:1281-6. PMID: 9077537
16. Kantele A, Westerholm M, Kantele JM, Makela PH, Savilahti E. Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. Vaccine. 1999; 17:229-36. PMID: 9987158
17. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol. 2003; 3:822-9. PMID: 14523388
18. Krieg C, Maier R, Meyerhans A. Gut-homing (alpha(4)beta(7)(+)) Th1 memory responses after inactivated poliovirus immunization in poliovirus orally pre-immunized donors. The Journal of general virology. 2004; 85:1571-9. PMID: 15166441
19. Jafari H, Deshpande JM, Sutter RW, Bahl S, Verma H, Ahmad M, et al. Polio eradication. Efficacy of inactivated poliovirus vaccine in India. Science (New York, NY). 2014; 345:922-5.
20. Expanded Programme on Immunization. (WHO/EPI/RD/91.3 Rev 1) Geneva, World Health Organization; 1991
21. th ed. Philadelphia: W.B. Saunders. 2013:598-645.
22. World Health Organization Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. The Journal of infectious diseases. 1997; 175 Suppl 1:S215-27. PMID: 9203720
23. Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MM, et al. Fractional doses of inactivated poliovirus vaccine in Oman. The New England journal of medicine. 2010; 362:2351-9. doi: 10.1056/NEJMoa0909383 PMID: 20573923
24. Quiding-Jarbrink M, Lakew M, Nordstrom I, Banchereau J, Butcher E, Holmgren J, et al. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur J Immunol. 1995; 25:322-7. PMID: 7533081
25. Team RC. A language and environment for statistical computing. R Foundation for Statistical Computing. 2014.
26. John J, Giri S, Karthikeyan AS, Iturriza-Gomara M, Muliyil J, Abraham A, et al. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial. Lancet. 2014; 384:1505-12. doi: 10.1016/S0140-6736(14)60934-X PMID: 25018120
27. Uhlig H, Dernick R. Intertypic cross-neutralization of polioviruses by human monoclonal antibodies. Virology. 1988; 163:214-7. PMID: 2831657
28. Chen Z, Fischer ER, Kouiavskaia D, Hansen BT, Ludtke SJ, Bidzhieva B, et al. Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor. Proc Natl Acad Sci U S A. 2013; 110:20242-7. doi: 10.1073/pnas.1320041110 PMID: 24277851
29. Estivariz CF, Jafari H, Sutter RW, John TJ, Jain V, Agarwal A, et al. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial. The Lancet Infectious diseases. 2012; 12:128-35. doi: 10.1016/S1473-3099(11)70190-6 PMID: 22071249
30. Grassly NC, Jafari H, Bahl S, Durrani S, Wenger J, Sutter RW, et al. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. The Journal of infectious diseases. 2010; 201:1535-43. doi: 10.1086/651952 PMID: 20367459